REPORT ID 4327

Global Companion Animal Specialty Drugs Market Size, Status and Forecast 2022

Publish Date
18-Dec-17
Pages
94
Format
Electronic (PDF)

This report studies the global Companion Animal Specialty Drugs market, analyzes and researches the Companion Animal Specialty Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Bayer
    Elanco
    Merial
    Zoetis
    Aratana therapeutics
    Beaphar
    Henry Schein
    Mars
    The J.M Smucker Company

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Vaccines
    Antibiotics
    Parasiticides
    Feed additives

Market segment by Application, Companion Animal Specialty Drugs can be split into
    Veterinary hospitals
    Pet care clinics
    Pharmacy stores

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Companion Animal Specialty Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Companion Animal Specialty Drugs
    1.1  Companion Animal Specialty Drugs Market Overview
        1.1.1 Companion Animal Specialty Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Companion Animal Specialty Drugs Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Companion Animal Specialty Drugs Market by Type
        1.3.1 Vaccines
        1.3.2 Antibiotics
        1.3.3 Parasiticides
        1.3.4 Feed additives
    1.4 Companion Animal Specialty Drugs Market by End Users/Application
        1.4.1 Veterinary hospitals
        1.4.2 Pet care clinics
        1.4.3 Pharmacy stores

2 Global Companion Animal Specialty Drugs Competition Analysis by Players
    2.1 Companion Animal Specialty Drugs Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Bayer
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Companion Animal Specialty Drugs Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Elanco
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Companion Animal Specialty Drugs Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Merial
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Companion Animal Specialty Drugs Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Zoetis
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Companion Animal Specialty Drugs Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Aratana therapeutics
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Companion Animal Specialty Drugs Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Beaphar
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Companion Animal Specialty Drugs Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Henry Schein
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Companion Animal Specialty Drugs Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Mars
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Companion Animal Specialty Drugs Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 The J.M Smucker Company
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Companion Animal Specialty Drugs Revenue (Value) (2012-2017)
        3.9.5 Recent Developments

4 Global Companion Animal Specialty Drugs Market Size by Type and Application (2012-2017)
    4.1 Global Companion Animal Specialty Drugs Market Size by Type (2012-2017)
    4.2 Global Companion Animal Specialty Drugs Market Size by Application (2012-2017)
    4.3 Potential Application of Companion Animal Specialty Drugs in Future
    4.4 Top Consumer/End Users of Companion Animal Specialty Drugs

5 United States Companion Animal Specialty Drugs Development Status and Outlook
    5.1 United States Companion Animal Specialty Drugs Market Size (2012-2017)
    5.2 United States Companion Animal Specialty Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Companion Animal Specialty Drugs Development Status and Outlook
    6.1 EU Companion Animal Specialty Drugs Market Size (2012-2017)
    6.2 EU Companion Animal Specialty Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Companion Animal Specialty Drugs Development Status and Outlook
    7.1 Japan Companion Animal Specialty Drugs Market Size (2012-2017)
    7.2 Japan Companion Animal Specialty Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Companion Animal Specialty Drugs Development Status and Outlook
    8.1 China Companion Animal Specialty Drugs Market Size (2012-2017)
    8.2 China Companion Animal Specialty Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Companion Animal Specialty Drugs Development Status and Outlook
    9.1 India Companion Animal Specialty Drugs Market Size (2012-2017)
    9.2 India Companion Animal Specialty Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Companion Animal Specialty Drugs Development Status and Outlook
    10.1 Southeast Asia Companion Animal Specialty Drugs Market Size (2012-2017)
    10.2 Southeast Asia Companion Animal Specialty Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Companion Animal Specialty Drugs Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Companion Animal Specialty Drugs Revenue and Growth Rate (2017-2022)
        11.1.2 EU Companion Animal Specialty Drugs Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Companion Animal Specialty Drugs Revenue and Growth Rate (2017-2022)
        11.1.4 China Companion Animal Specialty Drugs Revenue and Growth Rate (2017-2022)
        11.1.5 India Companion Animal Specialty Drugs Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Companion Animal Specialty Drugs Revenue and Growth Rate (2017-2022)
    11.2 Global Companion Animal Specialty Drugs Market Size (Value) by Type (2017-2022)
    11.3 Global Companion Animal Specialty Drugs Market Size by Application (2017-2022)

12 Companion Animal Specialty Drugs Market Dynamics
    12.1 Companion Animal Specialty Drugs Market Opportunities
    12.2 Companion Animal Specialty Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Companion Animal Specialty Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Companion Animal Specialty Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source